Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

532 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 16,5% cutaquig - - - - 1件: 65 💬
2 36-482-hyaluronoglucosaminidase ph20 (rhuph20) Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 1件: 65 💬
3 [na] - - - - 7件: 6, 11, 35, 46, 53, 65, 299 💬
4 A10bk03 - - - - 1件: 65 💬
5 Abatacept Abatacept 1件: D03203 💬 2件: CD80, CD86 💬 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
6 Acoziborole (scyx-7158) SCYX-7158 - - - 1件: 65 💬
7 Ada gene transfer - - - - 1件: 65 💬
8 Ada pbsc - - - - 1件: 65 💬
9 Ada umbilical cord blood cells - - - - 1件: 65 💬
10 Adagen - - - - 1件: 65 💬
11 Adenosine Adenosine 1件: D00045 💬 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 13, 58, 65 💬
12 Administration of drug (interferon-gamma 1-b) subcutaneously - - - - 1件: 65 💬
13 Adverse reactions of gammagard subcutaneously at week 12 - - - - 1件: 65 💬
14 Adverse reactions of gammagard subcutaneously at week 24 - - - - 1件: 65 💬
15 Adverse reactions of gammagard subcutaneously at week 36 - - - - 1件: 65 💬
16 Adverse reactions of gammagard subdermally at week 12 - - - - 1件: 65 💬
17 Adverse reactions of gammagard subdermally at week 24 - - - - 1件: 65 💬
18 Adverse reactions of gammagard subdermally at week 36 - - - - 1件: 65 💬
19 Aldesleukin Aldesleukin 1件: D00748 💬 3件: IL2RA, IL2RB, IL2RG 💬 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 4件: 49, 65, 96, 97 💬
20 Alefacept Alefacept 1件: D02800 💬 1件: CD58 💬 2件: Cell adhesion molecules, Epstein-Barr virus infection 6件: 37, 60, 65, 164, 284, 285 💬
21 Alemtuzumab Alemtuzumab 1件: D02802 💬 - - 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬
22 Alemtuzumab 0.2 mg Alemtuzumab 1件: D02802 💬 - - 2件: 65, 164 💬
23 Alemtuzumab 0.3 mg Alemtuzumab 1件: D02802 💬 - - 2件: 65, 164 💬
24 Alentuzumab (campath) - - - - 1件: 65 💬
25 Allogeneic peripheral blood stem cell - - - - 1件: 65 💬
26 Anti-cd45 - - - - 3件: 60, 65, 285 💬
27 Anti-thymocyte globulin - - - - 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
28 Anti-thymocyte globulin (rabbit) Rabbit - - - 4件: 60, 65, 96, 285 💬
29 Antithymocyte globulin - - - - 3件: 60, 65, 284 💬
30 Aproart - - - - 1件: 65 💬
31 Autologous cd34+ cell transduced with g2scid vector - - - - 1件: 65 💬
32 Autologous cd34+ cells transduced ex-vivo with the pcclchimgp91/vsvg lentiviral vector - - - - 1件: 65 💬
33 Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy - - - - 1件: 65 💬
34 Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence - - - - 1件: 65 💬
35 Autologous cd34+ hscs transduced ex vivo with efs lentiviral vector encoding for the human ada gene - - - - 1件: 65 💬
36 Autologous cd34+cells transduced with the w1.6_hwasp_wpre (vsvg) lentiviral vector - - - - 1件: 65 💬
37 Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv) Adenosine 1件: D00045 💬 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 65 💬
38 Azathioprine Azathioprine 2件: D00238, D03033 💬 - - 20件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
39 B-lymphocyte stimulator (blys) - - - - 1件: 65 💬
40 Bacteriophage - - - - 1件: 65 💬
41 Basiliximab Basiliximab 1件: D03058 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 6件: 2, 50, 65, 97, 222, 228 💬
42 Benznidazole Benznidazole 1件: D02489 💬 - - 1件: 65 💬
43 Biological sampling - - - - 1件: 65 💬
44 Bivigam - - - - 1件: 65 💬
45 Bms-188667 - - - - 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬
46 Bpx-501 t cells - - - - 4件: 65, 284, 285, 326 💬
47 Bt090 - - - - 1件: 65 💬
48 Bt524 - - - - 1件: 65 💬
49 Bt595 - - - - 2件: 63, 65 💬
50 Bt681 - - - - 1件: 65 💬
51 Busilvex - - - - 4件: 19, 36, 60, 65 💬
52 Busilvex - 6 mg/ml - concentrato per soluzione per infusione - uso endovenoso - flaconcino - 10 ml 8 flaconcini - - - - 2件: 19, 65 💬
53 Busulfan Busulfan 1件: D00248 💬 - - 13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
54 Busulfan iv Busulfan 1件: D00248 💬 - - 1件: 65 💬
55 Busulfan test dose Busulfan 1件: D00248 💬 - - 1件: 65 💬
56 Busulfan, cyclophosphamide, atg, gcsf Busulfan 3件: D00248, D00287, D07760 💬 - - 2件: 65, 284 💬
57 Busulfan, fludarabine and atg Busulfan 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
58 Busulfan, fludarabine, atg, tli Busulfan 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 284 💬
59 C1 esterase inhibitor (human) - - - - 1件: 65 💬
60 C1 esterase inhibitor human - - - - 1件: 65 💬
61 C1 inhibitor Human C1-esterase inhibitor - - - 1件: 65 💬
62 C1 inhibitor concentrate Human C1-esterase inhibitor - - - 1件: 65 💬
63 C1-esterase inhibitor [recombinant] (c1-inh-r) Human C1-esterase inhibitor - - - 1件: 65 💬
64 C1-inh Human C1-esterase inhibitor - - - 1件: 65 💬
65 Campath - - - - 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬
66 Campath -1h - - - - 1件: 65 💬
67 Campath 1h - - - - 4件: 60, 65, 164, 285 💬
68 Campath, fludarabine, cyclophosphamide Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 284 💬
69 Cd3/cd19 neg allogeneic bmt - - - - 1件: 65 💬
70 Cd3/cd19 negative allogeneic hematopoietic stem cells - - - - 1件: 65 💬
71 Cd34 stem cell selection therapy - - - - 3件: 60, 65, 284 💬
72 Cd34+ - - - - 1件: 65 💬
73 Cd34+ cells transduced with ada retrovir - - - - 1件: 65 💬
74 Cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1a-h?c-opt - - - - 1件: 65 💬
75 Cd34+cells - - - - 2件: 65, 285 💬
76 Cd45ra-depleted dli - - - - 2件: 60, 65 💬
77 Cdz173 - - - - 2件: 53, 65 💬
78 Chloride Chloride ion - - - 25件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬
79 Cryopreserved efs-ada lv transduced patient cd34+ cells - - - - 1件: 65 💬
80 Cryopreserved g2scid lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
81 Cultured thymus tissue for implantation (ctti) - - - - 1件: 65 💬
82 Cultured thymus tissue implantation (ctti) - - - - 1件: 65 💬
83 Cutaquig - - - - 1件: 65 💬
84 Cuvitru - - - - 1件: 65 💬
85 Cuvitru 200 mg/ml solution for subcutaneous injection - - - - 1件: 65 💬
86 Cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
87 Cyclophosphamide (cytoxan) Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
88 Cyclophosphamide 30 Cyclophosphamide 2件: D00287, D07760 💬 - - 3件: 65, 285, 326 💬
89 Cyclophosphamide 40 Cyclophosphamide 2件: D00287, D07760 💬 - - 3件: 65, 285, 326 💬
90 Cyclophosphamide dose level 1 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
91 Cyclophosphamide dose level 2 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
92 Cyclophosphamide dose level 3 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
93 Cyclophosphamide dose level 4 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
94 Cyclophosphamide post transplant Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
95 Cyclosporine Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
96 Cyclosporins - - - - 4件: 53, 60, 65, 222 💬
97 Daclizumab Daclizumab 1件: D03639 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 7件: 13, 56, 60, 65, 97, 283, 284 💬
98 Danazol Danazol 1件: D00289 💬 3件: AR, ESR1, PGR 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 5件: 60, 63, 64, 65, 285 💬
99 Data collection - - - - 1件: 65 💬
100 Db289 - - - - 1件: 65 💬
101 Depletion in cd45ra graft donor - - - - 1件: 65 💬
102 Device: cell processing for tcrabeta+/cd19+ depletion - - - - 1件: 65 💬
103 Device: cell processing for tcraß+/cd19+ depletion - - - - 1件: 65 💬
104 Device: chrono super pid then generic syringe-gammanorm - - - - 1件: 65 💬
105 Device: clinimacs - - - - 2件: 60, 65 💬
106 Device: clinimacs® cd34 reagent system cell sorter device - - - - 1件: 65 💬
107 Device: continuous glucose monitor Dextrose, unspecified form - - - 1件: 65 💬
108 Device: generic syringe then chrono super pid-gammanorm - - - - 1件: 65 💬
109 Device: isolex 300i magnetic cell selector - - - - 1件: 65 💬
110 Device: miltenyi clinimacs - - - - 2件: 62, 65 💬
111 Device: miltenyi clinimacs selection system - - - - 1件: 65 💬
112 Device: unrelated pbsc with t cell depletion - - - - 1件: 65 💬
113 Dexametasone fosfato sodico - - - - 1件: 65 💬
114 Dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
115 Dexamethasone 21-dihydrogen phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
116 Dexamethasone sodium phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 65, 70, 96 💬
117 Dexamethasone sodium phosphate ph. eur. Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
118 Dextrose Dextrose, unspecified form - - - 4件: 56, 60, 65, 70 💬
119 Dextrose, 5% in water Dextrose, unspecified form 1件: D00001 💬 - - 1件: 65 💬
120 Diagnostic test: blood drawing in healthy controls - - - - 1件: 65 💬
121 Diagnostic test: blood drawing in patients with was - - - - 1件: 65 💬
122 Diagnostic test: functional and antigenic c1 inhibitor Human C1-esterase inhibitor - - - 1件: 65 💬
123 Diagnostic test: oral glucose tolerance test Dextrose, unspecified form - - - 3件: 13, 65, 299 💬
124 Diagnostic test: rna and neopterin detection Neopterin - - - 1件: 65 💬
125 Donor peripheral blood stem cells. - - - - 1件: 65 💬
126 Ef1as-ada lentiviral vector gene modified autologous cd34+ cells - - - - 1件: 65 💬
127 Ef1as-ada lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
128 Efficacy of gammagard subcutaneously at week 12 - - - - 1件: 65 💬
129 Efficacy of gammagard subcutaneously at week 24 - - - - 1件: 65 💬
130 Efficacy of gammagard subcutaneously at week 36 - - - - 1件: 65 💬
131 Efficacy of gammagard subdermally at week 12 - - - - 1件: 65 💬
132 Efficacy of gammagard subdermally at week 24 - - - - 1件: 65 💬
133 Efficacy of gammagard subdermally at week 36 - - - - 1件: 65 💬
134 Eflornithine Eflornithine 1件: D07883 💬 1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 1件: 65 💬
135 Eflornithine plus nifurtimox combination therapy Eflornithine 2件: D00833, D07883 💬 1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 1件: 65 💬
136 Elapegademase Elapegademase 1件: D11017 💬 1件: ADA 💬 3件: Metabolic pathways, Primary immunodeficiency, Purine metabolism 1件: 65 💬
137 Elapegademase-lvlr Elapegademase 1件: D11017 💬 1件: ADA 💬 3件: Metabolic pathways, Primary immunodeficiency, Purine metabolism 1件: 65 💬
138 Eltrombopag Eltrombopag 1件: D03978 💬 - - 5件: 60, 63, 65, 284, 285 💬
139 Empagliflozin Empagliflozin 1件: D10459 💬 - - 3件: 65, 72, 257 💬
140 Ep2006 - - - - 1件: 65 💬
141 Ep2006 (filgrastim) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
142 Etoposide Etoposide 2件: D00125, D04107 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
143 Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector - - - - 1件: 65 💬
144 Ezn-2279 - - - - 1件: 65 💬
145 Fansidar (pyrimethamine and sulfadoxine) Pyrimethamine 2件: D00488, D00580 💬 - - 1件: 65 💬
146 Fexinidazole Fexinidazole 1件: D11252 💬 - - 1件: 65 💬
147 Fibrinogen Fibrinogen human - - - 3件: 14, 65, 288 💬
148 Fibrinogen (coagulation factori) Fibrinogen human - - - 1件: 65 💬
149 Fibrinogen concentrate from human plasma Fibrinogen human - - - 1件: 65 💬
150 Filgrastim Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 27件: 2, 6, 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
151 Filgrastim hexal Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
152 Filgrastim, alemtuzumab Alemtuzumab 2件: D02802, D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
153 Flebogamma 5% dif - - - - 1件: 65 💬
154 Fludarabina Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 19, 65 💬
155 Fludarabina accord Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
156 Fludarabina teva - 25 mg/ml concentrato per soluzione iniettabile o per infusione 1 flaconcino di vetro da 2 ml Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
157 Fludarabine Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬
158 Fludarabine monophosphate Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 3件: 65, 284, 326 💬
159 Fludarabine phosphate Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬
160 Fludarabine phosphate 30 mg Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
161 Fludarabine phosphate 40 mg Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
162 Fludarabine, busulfan, thymoglobulin Antithymocyte immunoglobulin (rabbit) 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
163 Fludarabine, melphalan, thiotepa Fludarabine 4件: D00369, D00583, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
164 Fortecortin - - - - 2件: 28, 65 💬
165 Fortecortin inject 40 mg amp. - - - - 1件: 65 💬
166 Fucose Fucose - - - 1件: 65 💬
167 G-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 16件: 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
168 G-csf for conditioning before hsct. Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
169 G1xcg - - - - 1件: 65 💬
170 G1xcgd transduced cd34+ cells - - - - 1件: 65 💬
171 Gadolinium Gadolinium - - - 6件: 13, 34, 46, 58, 65, 86 💬
172 Gadolinium for abdomen Gadolinium - - - 1件: 65 💬
173 Gadolinium for lower back Gadolinium - - - 1件: 65 💬
174 Gammagard liquid - - - - 1件: 65 💬
175 Gammagard s/d (solvent/detergent) - - - - 1件: 65 💬
176 Gammaglobulin - - - - 1件: 65 💬
177 Gammanorm - - - - 2件: 14, 65 💬
178 Gammanorm 165 mg/ml - - - - 1件: 65 💬
179 Gammaplex - - - - 2件: 63, 65 💬
180 Gammaplex (5%) - - - - 1件: 65 💬
181 Gammaplex (intravenous immunoglobulin) - - - - 1件: 65 💬
182 Gammaplex 10 - - - - 1件: 65 💬
183 Gamunex-c - - - - 1件: 65 💬
184 Gcsf - - - - 1件: 65 💬
185 Gene therapy method for cgd - - - - 1件: 65 💬
186 Gene transfer - - - - 1件: 65 💬
187 Gene-transduced autologous cd34+ stem cells - - - - 1件: 65 💬
188 Genetic: cl20-i4-ef1a-h?c-opt - - - - 1件: 65 💬
189 Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101) - - - - 1件: 65 💬
190 Genetic: infusion of autologous efs-ada lv cd34+ (otl-101) - - - - 1件: 65 💬
191 Genetic: infusion of autologous efs-ada lv cd34+ cells - - - - 1件: 65 💬
192 Genetically modified autologous blood stem cells - - - - 1件: 65 💬
193 Glucose Dextrose, unspecified form - - - 15件: 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
194 Glycolic acid Glycolic acid - - - 1件: 65 💬
195 Glycosade - - - - 3件: 65, 256, 257 💬
196 Gold Gold - - - 38件: 2, 5, 6, 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
197 Granulocyte colony stimulating factor Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 6件: 2, 28, 36, 57, 65, 85 💬
198 Granulocyte colony stimulating factor (g-csf) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
199 Gtg003.08 - - - - 1件: 65 💬
200 Gvhd prophylaxis - - - - 2件: 60, 65 💬
201 Haemocomplettan p - - - - 1件: 65 💬
202 Haemocomplettan(r) p - - - - 1件: 65 💬
203 Haemocomplettan(r) p 1g/2g - - - - 1件: 65 💬
204 Haplo bm with t cell depletion - - - - 1件: 65 💬
205 Haploidentical hematopoietic cell transplantation - - - - 2件: 60, 65 💬
206 Hematopoetic stem cell transplantation - - - - 5件: 19, 65, 120, 160, 326 💬
207 Hematopoietic stem cell transplant - - - - 1件: 65 💬
208 Hizentra - - - - 4件: 14, 50, 51, 65 💬
209 Hizentra® - - - - 2件: 14, 65 💬
210 Horse -anti-thymocyte - - - - 1件: 65 💬
211 Hpc, a infusion - - - - 2件: 60, 65 💬
212 Htlp - - - - 1件: 65 💬
213 Human fibrinogen Fibrinogen human - - - 1件: 65 💬
214 Human fibrinogen concentrate Fibrinogen human - - - 1件: 65 💬
215 Human immunglobulin g (igg) - - - - 1件: 65 💬
216 Human immunoglobulin - - - - 2件: 63, 65 💬
217 Human immunoglobulin g Human immunoglobulin G - - - 4件: 14, 50, 63, 65 💬
218 Human normal immunoglobulin Human immunoglobulin G - - - 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
219 Human normal immunoglobulin (iv) Human immunoglobulin G - - - 4件: 11, 14, 63, 65 💬
220 Human normal immunoglobulin (ivig) Human immunoglobulin G - - - 2件: 50, 65 💬
221 Human normal immunoglobulin (subcutaneous - intramuscular immunoglobulin) Human immunoglobulin G - - - 1件: 65 💬
222 Human normal immunoglobulin (subcutaneous) Human immunoglobulin G - - - 1件: 65 💬
223 Human normal immunoglobulin for Human immunoglobulin G - - - 1件: 65 💬
224 Human normal immunoglobulin for intravenous administration Human immunoglobulin G - - - 3件: 14, 51, 65 💬
225 Human normal immunoglobulin for intravenous use Human immunoglobulin G - - - 2件: 63, 65 💬
226 Human normal immunoglobulin for intravenous use (ivig) Human immunoglobulin G - - - 1件: 65 💬
227 Human normal immunoglobulin for subcutaneous administration Human immunoglobulin G - - - 2件: 51, 65 💬
228 Human normal immunoglobulin for subcutaneous administration (igsc) Human immunoglobulin G - - - 1件: 65 💬
229 Human normal immunoglobulin g (igg > 98% purity) Human immunoglobulin G - - - 3件: 14, 63, 65 💬
230 Hyaluronidase Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 4件: 28, 51, 65, 331 💬
231 Hyaluronoglucosaminidase Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 1件: 65 💬
232 Hydroxyurea Hydroxyurea 1件: D00341 💬 1件: RRM2 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 8件: 3, 13, 19, 20, 65, 85, 86, 284 💬
233 Hyqvia - - - - 2件: 14, 65 💬
234 Hyqvia 100 mg/ml solution for infusion for subcutaneous use - - - - 1件: 65 💬
235 I10e - - - - 3件: 14, 63, 65 💬
236 Ibuprofen Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 6件: 13, 46, 65, 113, 271, 299 💬
237 Ifn-gamma - - - - 1件: 65 💬
238 Ig vena 50 g/l solution for infusion 100 ml vial + infusion set - - - - 2件: 63, 65 💬
239 Igg next generation - - - - 2件: 63, 65 💬
240 Ighy10 - - - - 1件: 65 💬
241 Igiv, 10% - - - - 2件: 14, 65 💬
242 Igiv-c 10% - - - - 1件: 65 💬
243 Ignextgen 16% - - - - 1件: 65 💬
244 Igng - - - - 1件: 65 💬
245 Igpro10 - - - - 3件: 14, 51, 65 💬
246 Igpro20 - - - - 4件: 14, 50, 51, 65 💬
247 Igsc 20% - - - - 1件: 65 💬
248 Igsc 20% 150 mg/kg - - - - 1件: 65 💬
249 Igsc 20% daily push versus 2 times per week pump - - - - 1件: 65 💬
250 Igsc 20% daily push versus every 2 weeks pump - - - - 1件: 65 💬
251 Igsc 20% daily push versus once a week pump - - - - 1件: 65 💬
252 Igsc, 16% - - - - 1件: 65 💬
253 Igsc, 20% - - - - 1件: 65 💬
254 Immune globulin infusion (human), 10% - - - - 1件: 65 💬
255 Immune globulin intravenous - - - - 1件: 65 💬
256 Immune globulin intravenous (human) - - - - 1件: 65 💬
257 Immune globulin intravenous (human) 5% liquid, ivig-sn™ - - - - 1件: 65 💬
258 Immune globulin intravenous (human), 10% - - - - 2件: 14, 65 💬
259 Immune globulin intravenous (human), 10% solution - - - - 1件: 65 💬
260 Immune globulin intravenous (human), 10% tvr (triple virally reduced) solution - - - - 1件: 65 💬
261 Immune globulin intravenous (igiv) - - - - 1件: 65 💬
262 Immune globulin intravenous [human], 10% caprylate/chromatography purified - - - - 1件: 65 💬
263 Immune globulin subcutaneos, 20% - - - - 1件: 65 💬
264 Immune globulin subcutaneous (human) - - - - 2件: 14, 65 💬
265 Immune globulin subcutaneous (human) (scig) - - - - 1件: 65 💬
266 Immune globulin subcutaneous (human), 20% - - - - 1件: 65 💬
267 Immune globulin subcutaneous (human), 20% caprylate/chromatography purified (igsc 20%) - - - - 1件: 65 💬
268 Immune globulin subcutaneous (human), 20% solution - - - - 1件: 65 💬
269 Immune globulin subcutaneous (human), 20%, caprylate/chromatography purified - - - - 1件: 65 💬
270 Immune globulin subcutaneous, 20% - - - - 1件: 65 💬
271 Immune globulin subcutaneous, 20% solution (igsc, 20%) - - - - 1件: 65 💬
272 Immunglobulin (human) - - - - 1件: 65 💬
273 Immunoglobulin g - - - - 7件: 11, 13, 14, 49, 50, 63, 65 💬
274 Immunoglobulin g (ig nextgen 16%) - - - - 1件: 65 💬
275 Immunoglobulin intravenous (human) - - - - 1件: 65 💬
276 Immunoglobulins intravenous (human) - - - - 1件: 65 💬
277 Immunoglobulins, normal human - - - - 1件: 65 💬
278 Immunological diagnosis tests - - - - 1件: 65 💬
279 Immunosuppression only conditioning (ioc) - - - - 1件: 65 💬
280 Immunosuppression only conditioning - closed with amendment l - - - - 1件: 65 💬
281 Increlex - - - - 4件: 65, 78, 96, 299 💬
282 Infliximab Infliximab 1件: D02598 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬
283 Inh - - - - 1件: 65 💬
284 Interferon gamma Interferon Gamma - - - 8件: 18, 65, 85, 107, 228, 299, 301, 326 💬
285 Interferon gamma-1b Interferon Gamma 1件: D00747 💬 2件: IFNGR1, IFNGR2 💬 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 7件: 18, 65, 85, 228, 299, 301, 326 💬
286 Interferon-gamma - - - - 1件: 65 💬
287 Interleukin-2 Human interleukin-2 - - - 8件: 2, 35, 49, 55, 65, 96, 97, 162 💬
288 Intratect - - - - 3件: 13, 35, 65 💬
289 Intravenous immunoglobulin infusion - - - - 1件: 65 💬
290 Intravenous infusion of transduced cells - - - - 1件: 65 💬
291 Itraconazole Itraconazole 1件: D00350 💬 - - 4件: 3, 65, 227, 299 💬
292 Iv treatment with igsc, 10% - - - - 1件: 65 💬
293 Ivig Human immunoglobulin G - - - 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬
294 Ivig-peg - - - - 1件: 65 💬
295 Jardiance - - - - 1件: 65 💬
296 Kedrion ivig 10% - - - - 1件: 65 💬
297 Kig10 - - - - 1件: 65 💬
298 Kineret - - - - 9件: 28, 41, 46, 49, 65, 106, 107, 266, 299 💬
299 Kiovig - - - - 2件: 14, 65 💬
300 Kiovig 100 mg/ml solution for infusion - - - - 2件: 14, 65 💬
301 Klh - - - - 2件: 13, 65 💬
302 Kvd900 - - - - 1件: 65 💬
303 Kvd900 100 mg film coated tablet - - - - 1件: 65 💬
304 L-fucose Fucose - - - 1件: 65 💬
305 Ladicell - - - - 1件: 65 💬
306 Ldt - - - - 1件: 65 💬
307 Lemtrada - - - - 2件: 13, 65 💬
308 Leniolisib Leniolisib 1件: D11158 💬 3件: PIK3CA, PIK3CB, PIK3CD 💬 103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 2件: 53, 65 💬
309 Lenograstim Lenograstim 1件: D03247 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 7件: 2, 13, 16, 18, 19, 57, 65 💬
310 Lentiviral g1xcgd gene therapy - - - - 1件: 65 💬
311 Lentiviral vector transduced cd34+ cells - - - - 1件: 65 💬
312 Lfb-igsc - - - - 1件: 65 💬
313 Mabthera - - - - 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
314 Mabthera - 2 fiale 100 mg 10 ml - - - - 2件: 19, 65 💬
315 Mavorixafor - - - - 1件: 65 💬
316 Mctls - - - - 1件: 65 💬
317 Melarsoprol Melarsoprol 1件: D00832 💬 - - 1件: 65 💬
318 Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d Eflornithine 2件: D00832, D07883 💬 1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 1件: 65 💬
319 Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d Melarsoprol 2件: D00832, D00833 💬 - - 1件: 65 💬
320 Melphalan Melphalan 1件: D00369 💬 - - 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
321 Mesna - - - - 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
322 Methotrexate Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
323 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
324 Methylprednisolone or prednisolone Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
325 Mmf - - - - 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬
326 Monitor Methamidophos - - - 18件: 2, 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
327 Mozobil - - - - 3件: 19, 65, 285 💬
328 Mozobil - 20 mg/ml - soluzione iniettabile - uso sottocutaneo - flaconcino (vetro) - 24 mg/1.2 ml 1 flaconcino - - - - 1件: 65 💬
329 Mozobil 20mg/ml vial (injectable solution for subcutaneous use) - - - - 1件: 65 💬
330 Mozobil 20mg/ml vial (injectable solution, subcutaneous use) - - - - 1件: 65 💬
331 Mozobil, - - - - 1件: 65 💬
332 Mycophenolate Mycophenolic acid 1件: D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
333 Mycophenolate mofetil Mycophenolate mofetil 4件: D00752, D05094, D05095, D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
334 Mycophenolate mofetil (mmf) Mycophenolate mofetil 4件: D00752, D05094, D05095, D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 7件: 13, 49, 51, 60, 65, 66, 222 💬
335 Myeloablative conditioning-closed with amendment l - - - - 1件: 65 💬
336 Myeloablative preparative regimen - - - - 3件: 62, 65, 284 💬
337 Myelostim - - - - 1件: 65 💬
338 Myelostim - 34 1 flaconcino liofilizzato 33.6 miu + siringa preriempita solvente 1 ml - - - - 2件: 19, 65 💬
339 Myelostim 34 milions ui/ml - powder and solvent for solution for injection/infusion - - - - 1件: 65 💬
340 Myelostim 34 milions ui/ml, powder and solvent for solution for injection or infusion - - - - 1件: 65 💬
341 Nanogam 100 mg/ml - - - - 1件: 65 💬
342 Nanogam® 50 mg/ml - - - - 1件: 65 💬
343 Ndv-3a - - - - 1件: 65 💬
344 Neopterin Neopterin - - - 1件: 65 💬
345 Newgam - - - - 3件: 14, 63, 65 💬
346 Newnorm - - - - 1件: 65 💬
347 Nifurtimox Nifurtimox 1件: D00833 💬 - - 1件: 65 💬
348 Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d Eflornithine 2件: D00833, D07883 💬 1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 1件: 65 💬
349 Nifurtimox-eflronithine combination treatment (nect) Nifurtimox 1件: D00833 💬 - - 1件: 65 💬
350 None - - - - 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬
351 Normal human immunoglobulin g Human immunoglobulin G - - - 1件: 65 💬
352 Noxafil - - - - 3件: 60, 65, 299 💬
353 Noxafil 40 mg/ml oral solution - - - - 1件: 65 💬
354 Octa-c1-inh Human C1-esterase inhibitor - - - 1件: 65 💬
355 Octagam - - - - 2件: 13, 65 💬
356 Octagam 10% - - - - 3件: 50, 63, 65 💬
357 Octagam 5% - - - - 2件: 13, 65 💬
358 Octagam 50 mg/ml oldatos infúzió - - - - 1件: 65 💬
359 Octanorm - - - - 2件: 50, 65 💬
360 Octanorm 16.5% - - - - 2件: 50, 65 💬
361 Omalizumab Omalizumab 1件: D05251 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 7件: 46, 53, 65, 98, 162, 226, 299 💬
362 Omalizumab (xolair) Omalizumab 1件: D05251 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 1件: 65 💬
363 Orencia - - - - 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬
364 Orencia® 125 mg solution for injection in pre-filled syringe - - - - 1件: 65 💬
365 Other hematological agents - - - - 1件: 65 💬
366 Other: - - - - 2件: 2, 65 💬
367 Other: 0.9% sodium chloride Chloride ion 1件: D02056 💬 - - 1件: 65 💬
368 Other: blood sampling for laboratory developed test (ldt) analysis - - - - 1件: 65 💬
369 Other: cultured thymus tissue implantation and parental parathyroid transplantation - - - - 1件: 65 💬
370 Other: cultured thymus tissue implantation with parathyroid transplantation - - - - 1件: 65 💬
371 Other: donor lymphocyte infusion - - - - 1件: 65 💬
372 Other: food diary - - - - 1件: 65 💬
373 Other: haematopoietic stem cell transplantation (hsct) - - - - 1件: 65 💬
374 Other: laboratory biomarker analysis - - - - 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬
375 Other: medical history questionnaires - - - - 1件: 65 💬
376 Other: modified mixed meal tolerance test - - - - 1件: 65 💬
377 Other: modified oral glucose tolerance test Dextrose, unspecified form - - - 1件: 65 💬
378 Other: palliative care - - - - 5件: 19, 65, 120, 160, 326 💬
379 Otl-101 - - - - 1件: 65 💬
380 Otl-103 - - - - 1件: 65 💬
381 Otl-103 dispersion for infusion - - - - 1件: 65 💬
382 Ovastat Treosulfan 1件: D07253 💬 - - 2件: 13, 65 💬
383 Ovastat 1000 Treosulfan 1件: D07253 💬 - - 2件: 13, 65 💬
384 Ovastat 1000 (treosulfan injection) Treosulfan 1件: D07253 💬 - - 1件: 65 💬
385 Ovastat 1000 mg, powder for solution for infusion Treosulfan 1件: D07253 💬 - - 1件: 65 💬
386 Ovastat 5000 Treosulfan 1件: D07253 💬 - - 2件: 13, 65 💬
387 Ovastat 5000 (treosulfan injection) Treosulfan 1件: D07253 💬 - - 1件: 65 💬
388 Ovastat 5000 mg, powder for solution for infusion Treosulfan 1件: D07253 💬 - - 1件: 65 💬
389 Palifermin Palifermin 1件: D05338 💬 1件: FGFR2 💬 13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 4件: 13, 38, 39, 65 💬
390 Pantoprazole Pantoprazole 2件: D02593, D05353 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 2件: 13, 65 💬
391 Pantoprazolo 20 mg gastro-resistant tablets - - - - 1件: 65 💬
392 Peg - - - - 9件: 6, 13, 46, 65, 78, 96, 97, 240, 299 💬
393 Peg-ada - - - - 1件: 65 💬
394 Peg-ada ert - - - - 1件: 65 💬
395 Peg-interleukin-2 Human interleukin-2 - - - 1件: 65 💬
396 Pentamidine Pentamidine 2件: D00834, D08333 💬 - - 1件: 65 💬
397 Peripheral blood stem cells - - - - 2件: 51, 65 💬
398 Pha-022121 - - - - 1件: 65 💬
399 Phagocyte oxidase subunit transduced cd34 hematopoietic stem cells - - - - 1件: 65 💬
400 Phosphate Phosphate ion - - - 30件: 2, 3, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬
401 Pid - - - - 1件: 65 💬
402 Pioglitazone Pioglitazone 2件: D00945, D08378 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
403 Plerixafor Plerixafor 1件: D08971 💬 1件: CXCR4 💬 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 5件: 20, 51, 65, 285, 299 💬
404 Plerixafor for conditioning before hsct. Plerixafor 1件: D08971 💬 1件: CXCR4 💬 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 1件: 65 💬
405 Pncj pps - - - - 1件: 65 💬
406 Pneumo 23 - - - - 1件: 65 💬
407 Polyclonal igg - - - - 1件: 65 💬
408 Posaconazole Posaconazole 1件: D02555 💬 - - 3件: 60, 65, 299 💬
409 Posaconazole (psz) Posaconazole 1件: D02555 💬 - - 1件: 65 💬
410 Pps - - - - 1件: 65 💬
411 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
412 Prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
413 Prevenar - - - - 1件: 65 💬
414 Privigen - - - - 4件: 11, 14, 51, 65 💬
415 Privigen® - - - - 3件: 14, 63, 65 💬
416 Procedure: allo bmt - - - - 1件: 65 💬
417 Procedure: allogeneic bone marrow transplantation - - - - 6件: 60, 65, 96, 164, 284, 285 💬
418 Procedure: allogeneic hematopoietic stem cell transplantation - - - - 8件: 28, 51, 60, 62, 65, 164, 284, 285 💬
419 Procedure: allogeneic hsc - - - - 1件: 65 💬
420 Procedure: allogeneic hsct - - - - 1件: 65 💬
421 Procedure: blood draw - - - - 5件: 6, 19, 65, 231, 299 💬
422 Procedure: blood sample - - - - 1件: 65 💬
423 Procedure: ct scan - - - - 1件: 65 💬
424 Procedure: cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
425 Procedure: hematopoietic stem cell transplantation - - - - 3件: 13, 65, 285 💬
426 Procedure: in vitro-treated peripheral blood stem cell transplantation - - - - 2件: 60, 65 💬
427 Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation - - - - 6件: 28, 51, 60, 62, 65, 285 💬
428 Procedure: peripheral blood stem cell transplantation - - - - 11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬
429 Procedure: stem cell infusion - - - - 5件: 28, 60, 65, 284, 285 💬
430 Procedure: stem cell transplant - - - - 5件: 19, 20, 65, 164, 284 💬
431 Procedure: stem cell transplantation - - - - 6件: 19, 51, 60, 62, 65, 326 💬
432 Procedure: total body irradiation - - - - 6件: 19, 20, 51, 60, 65, 285 💬
433 Procedure: total lymphoid irradiation - - - - 3件: 65, 284, 326 💬
434 Procedure: umbilical cord blood transplantation - - - - 5件: 60, 65, 284, 285, 326 💬
435 Proleukin - - - - 3件: 2, 49, 65 💬
436 Proleukin® s - - - - 1件: 65 💬
437 Promacta - - - - 2件: 63, 65 💬
438 Prometic's immune globulin intravenous 10% - - - - 1件: 65 💬
439 Psrs11.efs.il2rg.pre* retroviral vector - - - - 1件: 65 💬
440 Psrs11.efs.il2rg.pre* retroviral vector transduce - - - - 1件: 65 💬
441 Psrs11.efs.il2rg.pre* retroviral vector transduced cells - - - - 1件: 65 💬
442 Pth - - - - 2件: 65, 235 💬
443 Pth 1-34 Teriparatide 1件: D06078 💬 1件: PTH1R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 2件: 65, 235 💬
444 Purified vero cell vaccine) - - - - 1件: 65 💬
445 Pyrimethamine Pyrimethamine 1件: D00488 💬 - - 4件: 2, 4, 19, 65 💬
446 R-hil-18bp - - - - 1件: 65 💬
447 Rabbit Rabbit - - - 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬
448 Rabbit anti-thymocyte globulin Rabbit - - - 2件: 49, 65 💬
449 Radiation: radiation therapy - - - - 5件: 34, 60, 65, 284, 285 💬
450 Radiation: total body 200cgy - - - - 1件: 65 💬
451 Radiation: total body irradiation - - - - 7件: 36, 49, 51, 60, 65, 283, 284 💬
452 Radiation: total body irradiation (tbi) - - - - 3件: 60, 65, 285 💬
453 Radiation: total lymphoid irradiation (tli) - - - - 2件: 60, 65 💬
454 Radiation: total-body irradiation - - - - 9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
455 Rag1 lv cd34+ cells - - - - 1件: 65 💬
456 Ranitidine Ranitidine 2件: D00422, D00673 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 2件: 13, 65 💬
457 Recombinant human hyaluronidase Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 2件: 28, 65 💬
458 Recombinant human hyaluronidase (rhuph20) Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 1件: 65 💬
459 Recombinant human hyaluronidase (rhuph20)+ immune globulin intravenous (igiv) Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 1件: 65 💬
460 Recombinant human hyaluronidase + immune globulin intravenous Hyaluronidase 3件: D04455, D04456, D06604 💬 - - 1件: 65 💬
461 Reduced intensity conditioning - - - - 2件: 19, 65 💬
462 Reduced intensity conditioning (ric) - - - - 1件: 65 💬
463 Reduced intensity preparative regimen - - - - 3件: 62, 65, 284 💬
464 Reduced toxicity ablative regimen - - - - 3件: 62, 65, 284 💬
465 Retroviral sf71-gp91phox transduced cd34+ cells - - - - 1件: 65 💬
466 Retrovirus-mediated gene transfer - - - - 1件: 65 💬
467 Rhucd40l - - - - 1件: 65 💬
468 Ri-002 - - - - 1件: 65 💬
469 Rifaximin Rifaximin 1件: D02554 💬 - - 6件: 6, 65, 96, 97, 99, 296 💬
470 Rimiducid Rimiducid 1件: D11195 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 6件: 19, 60, 65, 284, 285, 326 💬
471 Rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
472 Rituximab (rtx) and azathioprine (aza) Azathioprine 3件: D00238, D02994, D03033 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 65 💬
473 Rivogenlecleucel - - - - 6件: 19, 60, 65, 284, 285, 326 💬
474 Romiplostim Romiplostim 1件: D08990 💬 1件: MPL 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 4件: 60, 63, 64, 65 💬
475 Rp-l201 - - - - 1件: 65 💬
476 Rtx - - - - 4件: 11, 65, 222, 240 💬
477 Sc treatment with igsc, 10% with rhuph20 followed by iv/igsc, 10% only (safety) - - - - 1件: 65 💬
478 Sc treatment with igsc, 10% with rhuph20 followed by sc/igsc, 10% only (safety) - - - - 1件: 65 💬
479 Scid screening - - - - 1件: 65 💬
480 Scyx-7158 SCYX-7158 - - - 1件: 65 💬
481 Sirolimus Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 35件: 6, 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬
482 Sodium chloride Chloride ion 1件: D02056 💬 - - 20件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬
483 Somatic gene-therapy by x-cgd - - - - 1件: 65 💬
484 Sta-5326 - - - - 2件: 65, 96 💬
485 Stelara (ustekinumab) Ustekinumab 1件: D09214 💬 3件: IL12A, IL12B, IL23A 💬 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 1件: 65 💬
486 Stem cell transplant - - - - 2件: 60, 65 💬
487 Stem cell transplantation - - - - 10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬
488 Strimvelis - - - - 1件: 65 💬
489 Subcuvia - - - - 3件: 14, 49, 65 💬
490 Subgam - - - - 1件: 65 💬
491 Sulfadoxine Sulfadoxine 1件: D00580 💬 - - 1件: 65 💬
492 Suspension of autologous cd34+cells transduced with the g1xcgd viral vector - - - - 1件: 65 💬
493 T-cell depleted & cd34+select/w/stemcell enriched product - - - - 1件: 65 💬
494 Tabelecleucel - - - - 1件: 65 💬
495 Tablets fexinidazole Fexinidazole 1件: D11252 💬 - - 1件: 65 💬
496 Tacrolimus Tacrolimus 2件: D00107, D08556 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 32件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
497 Tacrolimus (tacro) Tacrolimus 2件: D00107, D08556 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 65 💬
498 Tadekinig alfa Tadekinig alfa - - - 1件: 65 💬
499 Tbx-1400 - - - - 1件: 65 💬
500 Tcr alfa beta t cell depletion - - - - 1件: 65 💬
501 Thalidomide Thalidomide 1件: D00754 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬
502 Therapeutic allogeneic lymphocytes - - - - 3件: 60, 65, 285 💬
503 There is no recommended inn - - - - 1件: 65 💬
504 Thiotepa Thiotepa 1件: D00583 💬 - - 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬
505 Thiotepa--escalated dose Thiotepa 1件: D00583 💬 - - 4件: 19, 20, 65, 284 💬
506 Thiotepa--single daily dose Thiotepa 1件: D00583 💬 - - 4件: 19, 20, 65, 284 💬
507 Thymoglobulin Antithymocyte immunoglobulin (rabbit) - - - 6件: 36, 51, 60, 65, 96, 326 💬
508 Thymus tissue for transplantation - - - - 1件: 65 💬
509 Thymus/parathyroid transplantation - - - - 2件: 65, 235 💬
510 Traditional treatment of cgd and tb - - - - 1件: 65 💬
511 Transduced lymphocytes - - - - 1件: 65 💬
512 Transduced patient cd34+ cells - - - - 1件: 65 💬
513 Transplant conditioning with mobilization and alemtuzumab Alemtuzumab 1件: D02802 💬 - - 1件: 65 💬
514 Transplant conditioning with mobilization only - - - - 1件: 65 💬
515 Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan Alemtuzumab 5件: D00369, D00583, D01907, D02802, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
516 Treosulfan Treosulfan 1件: D07253 💬 - - 3件: 13, 19, 65 💬
517 Tyf-il-2rg gene-modified autologous stem cells - - - - 1件: 65 💬
518 Unrelated bm with t cell depletion - - - - 1件: 65 💬
519 Unrelated cord blood - - - - 1件: 65 💬
520 Ustekinumab Ustekinumab 1件: D09214 💬 3件: IL12A, IL12B, IL23A 💬 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
521 Valacyclovir Valaciclovir 3件: D00398, D08664, D10518 💬 - - 1件: 65 💬
522 Valproic acid Valproic acid 1件: D00399 💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 10件: 3, 5, 26, 34, 65, 89, 90, 222, 256, 331 💬
523 Verorab® (pvrv - - - - 1件: 65 💬
524 Vigantol - - - - 4件: 13, 65, 96, 97 💬
525 Vitamin d3 Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 11件: 6, 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬
526 Vivaglobin - - - - 2件: 14, 65 💬
527 Vm106 - - - - 1件: 65 💬
528 Water Water 1件: D00001 💬 - - 22件: 2, 5, 6, 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬
529 X4p-001 - - - - 1件: 65 💬
530 Xifaxan - - - - 2件: 65, 94 💬
531 Zarzio - - - - 2件: 65, 285 💬
532 Zoledronate Zoledronic acid 4件: D01968, D06378, D06379, D08689 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 2件: 46, 65 💬

先頭へ